secwatch.observer — SEC 8-K summary
======================================

Issuer:     FOXO TECHNOLOGIES INC. (FOXO)
CIK:        0001812360
Form:       8-K
Filed at:   2023-10-16T23:59:59+00:00
Accession:  0001013762-23-004115
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 8.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FOXO signs $2M equity facility with ClearThink, receives USPTO patent for ML epigenetic biomarkers
--------------------------------------------------------------------------------

- Equity line agreement with ClearThink for up to $2M of common stock at 85% of lowest 10-day VWAP; 1M commitment shares.
- Securities Purchase Agreement for 2M restricted shares at $200,000 ($0.10/share) in two closings; subject to price adjustment if registration delayed.
- USPTO issues patent for machine learning model trained on DNA epigenetic data to determine biochemical states and medical conditions.
- Corrected Shares for Services Agreement with Joseph Gunnar removes inadvertently included convertible securities and fundamental transaction provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812360/000101376223004115/0001013762-23-004115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812360/000101376223004115/ea186737-8k_foxotech.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-004115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer